Clinical Cancer Research publishes articles that focus on innovative clinical and translational research bridging the laboratory and the clinic. Topics include targeted therapies; mechanisms of drug ...

Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...

Prevention and screening efforts accounted for 80% of the approximately 5.94 million cancer deaths that were averted from 1975 to 2020 in the United States, according to an NCI study.

A specific pattern of chromosomal gains and losses in cell-free DNA could help differentiate maternal cancers from benign conditions flagged by prenatal tests. This finding offers a promising ...

At the Annual Meeting of the Society of Urologic Oncology, Protara Therapeutics announced that TARA-002 showed high response rates in patients with non–muscle invasive bladder cancer who do not ...

Dietary fructose fuels tumor growth indirectly, a new study shows, with the liver converting the sugar into lipids that cancer cells scavenge to construct membranes for division.

Major Finding: A phase 1b trial demonstrated the safety of cretostimogene grenadenorepvec plus nivolumab in muscle-invasive bladder cancer (MIBC). Concept: Boosting immune checkpoint inhibition with ...

The Supreme Court of the United States (SCOTUS) heard arguments on whether the FDA unlawfully rejected two companies’ applications to sell flavored liquids for use in electronic cigarettes ...

1Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

Yale University School of Medicine, New Haven, Connecticut.

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, ...

This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license. This work is licensed under a Creative Commons Attribution 4.0 International ...